Following success across the UK’s National Health Service identifying breast, ovarian, and colorectal cancers years earlier than traditional methods, Khosla invests to bring to the U.S. Company’s AI ...

C the Signs AI model enhances early colorectal cancer (CRC) detection, achieving 93.8% sensitivity and 19.7% specificity. The model identified 29.4% of CRC patients as high-risk up to 5 years earlier ...

Please provide your email address to receive an email when new articles are posted on . C the Signs uses an AI-based cancer prediction system to detect cancers earlier. The company participated in the ...

C the Signs Ltd. recently received a capital injection of $8 million from Khosla Ventures to expand its AI-powered cancer prediction platform to the U.S. market.